{"id":225,"date":"2017-03-18T10:46:18","date_gmt":"2017-03-18T10:46:18","guid":{"rendered":"http:\/\/www.novacos-law.com\/en\/?p=225"},"modified":"2017-03-29T18:59:47","modified_gmt":"2017-03-29T17:59:47","slug":"novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/","title":{"rendered":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL"},"content":{"rendered":"<p>The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman<sup>\u00ae<\/sup>\u00a0for treatment of menopausal symptoms and Silicur<sup>\u00ae<\/sup>\u00a0for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the mid-term provide for 10 percent of DR.KADE&#8217;s total revenues in the OTC sector.<\/p>\n<p>NOVACOS advised DR.KADE on the acquisition with the following team:\u00a0Christian H\u00fcbner (Lead, Partner, M&amp;A\/Life Sciences) and Maria Heil (Partner, M&amp;A\/Life Sciences).<\/p>\n<p>This is our press release (in German language):\u00a0<a href=\"http:\/\/www.novacos-law.com\/en\/wp-content\/uploads\/sites\/3\/2017\/03\/pressemitteilung-novacos-16jan2017.pdf\">Pressemitteilung NOVACOS 16Jan2017<\/a>.<\/p>\n<p>The news coverage by Juve is accessible via the following <a href=\"http:\/\/www.juve.de\/nachrichten\/deals\/2017\/01\/pillen-deal-dr-kade-kauft-mit-clifford-spin-off-novacos-bei-hexal-ein\">link<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\u00ae\u00a0for treatment of menopausal symptoms and Silicur\u00ae\u00a0for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-225","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\u00ae for treatment of menopausal symptoms and Silicur\u00ae for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Christian H\u00fcbner\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#article\",\"name\":\"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL | NOVACOS\",\"headline\":\"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL\",\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/chuebner\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"},\"datePublished\":\"2017-03-18T10:46:18+01:00\",\"dateModified\":\"2017-03-29T18:59:47+02:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#webpage\"},\"articleSection\":\"News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/news\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#listItem\",\"name\":\"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#listItem\",\"position\":3,\"name\":\"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/category\\\/news\\\/#listItem\",\"name\":\"News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/chuebner\\\/#author\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/chuebner\\\/\",\"name\":\"Christian H\\u00fcbner\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e11655748d38e780ee52a7b13f0243a5a80a762252f6cd397e503dbcb5887fe?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Christian H\\u00fcbner\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#webpage\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/\",\"name\":\"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL | NOVACOS\",\"description\":\"The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\\u00ae for treatment of menopausal symptoms and Silicur\\u00ae for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/2017\\\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/chuebner\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/author\\\/chuebner\\\/#author\"},\"datePublished\":\"2017-03-18T10:46:18+01:00\",\"dateModified\":\"2017-03-29T18:59:47+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL | NOVACOS","description":"The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\u00ae for treatment of menopausal symptoms and Silicur\u00ae for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the","canonical_url":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#article","name":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL | NOVACOS","headline":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL","author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/chuebner\/#author"},"publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"},"datePublished":"2017-03-18T10:46:18+01:00","dateModified":"2017-03-29T18:59:47+02:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#webpage"},"isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#webpage"},"articleSection":"News"},{"@type":"BreadcrumbList","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","position":1,"name":"Home","item":"https:\/\/www.novacos-law.com\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/news\/#listItem","position":2,"name":"News","item":"https:\/\/www.novacos-law.com\/en\/category\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#listItem","name":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#listItem","position":3,"name":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL","previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/en\/category\/news\/#listItem","name":"News"}}]},{"@type":"Organization","@id":"https:\/\/www.novacos-law.com\/en\/#organization","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","url":"https:\/\/www.novacos-law.com\/en\/"},{"@type":"Person","@id":"https:\/\/www.novacos-law.com\/en\/author\/chuebner\/#author","url":"https:\/\/www.novacos-law.com\/en\/author\/chuebner\/","name":"Christian H\u00fcbner","image":{"@type":"ImageObject","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/1e11655748d38e780ee52a7b13f0243a5a80a762252f6cd397e503dbcb5887fe?s=96&d=mm&r=g","width":96,"height":96,"caption":"Christian H\u00fcbner"}},{"@type":"WebPage","@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#webpage","url":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/","name":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL | NOVACOS","description":"The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\u00ae for treatment of menopausal symptoms and Silicur\u00ae for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/www.novacos-law.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/#breadcrumblist"},"author":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/chuebner\/#author"},"creator":{"@id":"https:\/\/www.novacos-law.com\/en\/author\/chuebner\/#author"},"datePublished":"2017-03-18T10:46:18+01:00","dateModified":"2017-03-29T18:59:47+02:00"},{"@type":"WebSite","@id":"https:\/\/www.novacos-law.com\/en\/#website","url":"https:\/\/www.novacos-law.com\/en\/","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","inLanguage":"en-GB","publisher":{"@id":"https:\/\/www.novacos-law.com\/en\/#organization"}}]}},"aioseo_meta_data":{"post_id":"225","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2020-12-21 12:16:30","updated":"2025-07-25 08:57:34","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/en\/category\/news\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.novacos-law.com\/en"},{"label":"News","link":"https:\/\/www.novacos-law.com\/en\/category\/news\/"},{"label":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL","link":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/"}],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=225"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/225\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}